About Bavarian Nordic

Bavarian Nordic is a leading industrial biotechnology company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases with a large unmet medical need.

Our projects

PROSTVAC™ 
Prostate cancer vaccine

IMVAMUNE®
Smallpox vaccine

Cancer

Immunotherapy offers improved treatment options with better quality of life

Biodefence

Development of preventative countermeasures against biological weapons

Infectious diseases

Early stage projects in various infectious diseases

Annual Report 2009

9 March 2010
Today, Bavarian Nordic published its annual report 2009 - conference call today at 09 am (CET)


Download report
Conference call details and presentation

Subscribe

Subscribe to our mailinglist to receive company announcements and financial reports via e-mail.